Literature DB >> 22365162

Cardio-renal syndrome type 5: epidemiology, pathophysiology, and treatment.

Sachin S Soni1, Claudio Ronco, Rupesh Pophale, Ashish S Bhansali, Amit P Nagarik, Shriganesh R Barnela, Sonali S Saboo, Anuradha Raman.   

Abstract

The cardio-renal syndromes (CRS) recently were defined systematically as disorders of the heart or kidney whereby dysfunction of one organ leads to dysfunction of another. Five types of CRS are defined. The first four types describe acute or chronic cardio-renal or renocardiac syndromes. Type 5 CRS refers to secondary cardio-renal syndrome or cardio-renal involvement in systemic conditions. It is a clinical and pathophysiological entity to describe the concomitant presence of renal and cardiovascular dysfunction. Type 5 CRS can be acute or chronic and it does not strictly satisfy the definition of CRS. However, it encompasses many conditions in which combined heart and kidney dysfunction is observed. Because this entity has been described only recently there is limited information about the epidemiology, clinical course, and treatment of this condition.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22365162     DOI: 10.1016/j.semnephrol.2011.11.007

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  7 in total

1.  Prevalence and clinical features of patients with the cardiorenal syndrome admitted to an internal medicine ward.

Authors:  Antonietta Gigante; Marta Liberatori; Maria Ludovica Gasperini; Liborio Sardo; Francesca Di Mario; Barbara Dorelli; Biagio Barbano; Edoardo Rosato; Filippo Rossi Fanelli; Antonio Amoroso
Journal:  Cardiorenal Med       Date:  2014-05-06       Impact factor: 2.041

Review 2.  Cellular apoptosis in the cardiorenal axis.

Authors:  Grazia Maria Virzì; Anna Clementi; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

Review 3.  The Role of Endotoxin in the Setting of Cardiorenal Syndrome Type 5.

Authors:  Anna Clementi; Grazia Maria Virzì; Alessandra Brocca; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2017-06-24       Impact factor: 2.041

4.  Left Ventricular Mass and Intrarenal Arterial Stiffness as Early Diagnostic Markers in Cardiorenal Syndrome Type 5 due to Systemic Sclerosis.

Authors:  Antonietta Gigante; Giuseppe Barilaro; Biagio Barbano; Antonella Romaniello; Francesca Di Mario; Silvia Quarta; Maria Ludovica Gasperini; Gianluca Di Lazzaro Giraldi; Alessandro Laviano; Antonio Amoroso; Rosario Cianci; Edoardo Rosato
Journal:  Cardiorenal Med       Date:  2016-01-23       Impact factor: 2.041

Review 5.  Heart-kidney crosstalk and role of humoral signaling in critical illness.

Authors:  Grazia Virzì; Sonya Day; Massimo de Cal; Giorgio Vescovo; Claudio Ronco
Journal:  Crit Care       Date:  2014-01-06       Impact factor: 9.097

6.  Forced diuresis oriented by point-of-care ultrasound in cardiorenal syndrome type 5 due to light chain myeloma-The role of hepatic venogram: A case report.

Authors:  Andrea Galassi; Lorenza Magagnoli; Eliana Fasulo; Andrea Stucchi; Elena Restelli; Alessia Moro; Martina Violati; Mario Cozzolino
Journal:  Clin Case Rep       Date:  2021-03-16

7.  Cardiorenal syndrome type 5: in vitro cytotoxicity effects on renal tubular cells and inflammatory profile.

Authors:  Alessandra Brocca; Grazia Maria Virzì; Chiara Pasqualin; Silvia Pastori; Stefano Marcante; Massimo de Cal; Claudio Ronco
Journal:  Anal Cell Pathol (Amst)       Date:  2015-07-22       Impact factor: 2.916

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.